Protein Arginine Methyltransferase 5: a Potential Cancer Therapeutic Target

Overview

Journal Cell Oncol (Dordr)

Publisher Springer

Date 2021 Jan 20

PMID 33469838

Citations 19

Authors

Yuanyang Yuan

Hong Nie

Affiliations

Soon will be listed here.

Abstract

Background: PRMT5 is a type II protein arginine methyltransferase that methylates histone or non-histone proteins. Arginine methylation by PRMT5 has been implicated in gene transcription, ribosome biogenesis, RNA transport, pre-mRNA splicing and signal transduction. High expression of PRMT5 has been observed in various cancers and PRMT5 overexpression has been reported to improve cancer cell survival, proliferation, migration and metabolism and to inhibit cancer cell apoptosis. In addition, PRMT5 has been found to be required for cancer stem cell survival, self-renewal and differentiation. Several microRNAs have been shown to regulate PRMT5 expression. As PRMT5 has oncogene-like properties, several PRMT5 inhibitors have been used to explore their efficacy as potential drugs for different types of cancer, and three of them are now being tested in clinical trials.

Conclusions: In this review, we summarize current knowledge on the role of PRMT5 in cancer development and progression, including its functions and underlying mechanisms. In addition, we highlight the rapid development of PRMT5 inhibitors and summarize ongoing clinical trials for cancer therapy. By affecting both tumor cells and the tumor microenvironment, PRMT5 inhibitors may serve as effective anti-cancer agents, especially when combined with immune therapies.

Citing Articles

PADI4 facilitates stem-like properties and cisplatin resistance through upregulating PRMT2/IDs family in oesophageal squamous cell carcinoma.

Wang Z, Wu H, Li Z, Chen Z, Feng A, Chu Y Clin Transl Med. 2025; 15(3):e70272.

PMID: 40078091 PMC: 11904308. DOI: 10.1002/ctm2.70272.

CircGSK3β mediates PD-L1 transcription through miR-338-3p/PRMT5/H3K4me3 to promote breast cancer cell immune evasion and tumor progression.

Liang L, Gao M, Li W, Tang J, He Q, Zeng F Cell Death Discov. 2024; 10(1):426.

PMID: 39366935 PMC: 11452702. DOI: 10.1038/s41420-024-02197-8.

The interplay mechanism between IDH mutation, MGMT-promoter methylation, and PRMT5 activity in the progression of grade 4 astrocytoma: unraveling the complex triad theory.

Kurdi M, Alkhotani A, Sabbagh A, Faizo E, Lary A, Bamaga A Oncol Res. 2024; 32(6):1037-1045.

PMID: 38827324 PMC: 11136683. DOI: 10.32604/or.2024.051112.

Regulation of RORα Stability through PRMT5-Dependent Symmetric Dimethylation.

Xiong G, Obringer B, Jones A, Horton E, Xu R Cancers (Basel). 2024; 16(10).

PMID: 38791992 PMC: 11120602. DOI: 10.3390/cancers16101914.

Molecular Mechanisms of Medicinal Plant -derived Compound Securinine against Spinal Muscular Atrophy based on Network Pharmacology and Experimental Verification.

Zhang Y, He J, Xiang L, Tang X, Wang S, Li A Curr Pharm Des. 2024; 30(15):1178-1193.

PMID: 38561613 DOI: 10.2174/0113816128288504240321041408.

References

Mohammad H, Barbash O, Creasy C . Targeting epigenetic modifications in cancer therapy: erasing the roadmap to cancer. Nat Med. 2019; 25(3):403-418. DOI: 10.1038/s41591-019-0376-8. View

Baldwin G, Carnegie P . Specific enzymic methylation of an arginine in the experimental allergic encephalomyelitis protein from human myelin. Science. 1971; 171(3971):579-81. DOI: 10.1126/science.171.3971.579. View

Brostoff S, Eylar E . Localization of methylated arginine in the A1 protein from myelin. Proc Natl Acad Sci U S A. 1971; 68(4):765-9. PMC: 389038. DOI: 10.1073/pnas.68.4.765. View

Jarrold J, Davies C . PRMTs and Arginine Methylation: Cancer's Best-Kept Secret?. Trends Mol Med. 2019; 25(11):993-1009. DOI: 10.1016/j.molmed.2019.05.007. View

Stopa N, Krebs J, Shechter D . The PRMT5 arginine methyltransferase: many roles in development, cancer and beyond. Cell Mol Life Sci. 2015; 72(11):2041-59. PMC: 4430368. DOI: 10.1007/s00018-015-1847-9. View

Ma X, Lu Q, Grunstein M . A search for proteins that interact genetically with histone H3 and H4 amino termini uncovers novel regulators of the Swe1 kinase in Saccharomyces cerevisiae. Genes Dev. 1996; 10(11):1327-40. DOI: 10.1101/gad.10.11.1327. View

Pollack B, Kotenko S, He W, Izotova L, Barnoski B, Pestka S . The human homologue of the yeast proteins Skb1 and Hsl7p interacts with Jak kinases and contains protein methyltransferase activity. J Biol Chem. 1999; 274(44):31531-42. DOI: 10.1074/jbc.274.44.31531. View

Antonysamy S, Bonday Z, Campbell R, Doyle B, Druzina Z, Gheyi T . Crystal structure of the human PRMT5:MEP50 complex. Proc Natl Acad Sci U S A. 2012; 109(44):17960-5. PMC: 3497828. DOI: 10.1073/pnas.1209814109. View

Ho M, Wilczek C, Bonanno J, Xing L, Seznec J, Matsui T . Structure of the arginine methyltransferase PRMT5-MEP50 reveals a mechanism for substrate specificity. PLoS One. 2013; 8(2):e57008. PMC: 3581573. DOI: 10.1371/journal.pone.0057008. View

10.

Di Lorenzo A, Bedford M . Histone arginine methylation. FEBS Lett. 2010; 585(13):2024-31. PMC: 3409563. DOI: 10.1016/j.febslet.2010.11.010. View

11.

Kota S, Roening C, Patel N, Kota S, Baron R . PRMT5 inhibition promotes osteogenic differentiation of mesenchymal stromal cells and represses basal interferon stimulated gene expression. Bone. 2018; 117:37-46. PMC: 6317875. DOI: 10.1016/j.bone.2018.08.025. View

12.

Scaglione A, Patzig J, Liang J, Frawley R, Bok J, Mela A . PRMT5-mediated regulation of developmental myelination. Nat Commun. 2018; 9(1):2840. PMC: 6053423. DOI: 10.1038/s41467-018-04863-9. View

13.

Tee W, Pardo M, Theunissen T, Yu L, Choudhary J, Hajkova P . Prmt5 is essential for early mouse development and acts in the cytoplasm to maintain ES cell pluripotency. Genes Dev. 2010; 24(24):2772-7. PMC: 3003195. DOI: 10.1101/gad.606110. View

14.

Chiang K, Zielinska A, Shaaban A, Sanchez-Bailon M, Jarrold J, Clarke T . PRMT5 Is a Critical Regulator of Breast Cancer Stem Cell Function via Histone Methylation and FOXP1 Expression. Cell Rep. 2017; 21(12):3498-3513. PMC: 5746596. DOI: 10.1016/j.celrep.2017.11.096. View

15.

Tarighat S, Santhanam R, Frankhouser D, Radomska H, Lai H, Anghelina M . The dual epigenetic role of PRMT5 in acute myeloid leukemia: gene activation and repression via histone arginine methylation. Leukemia. 2015; 30(4):789-99. PMC: 8034866. DOI: 10.1038/leu.2015.308. View

16.

Pal S, Baiocchi R, Byrd J, Grever M, Jacob S, Sif S . Low levels of miR-92b/96 induce PRMT5 translation and H3R8/H4R3 methylation in mantle cell lymphoma. EMBO J. 2007; 26(15):3558-69. PMC: 1949000. DOI: 10.1038/sj.emboj.7601794. View

17.

Zhang B, Dong S, Zhu R, Hu C, Hou J, Li Y . Targeting protein arginine methyltransferase 5 inhibits colorectal cancer growth by decreasing arginine methylation of eIF4E and FGFR3. Oncotarget. 2015; 6(26):22799-811. PMC: 4673200. DOI: 10.18632/oncotarget.4332. View

18.

Blanc R, Richard S . Arginine Methylation: The Coming of Age. Mol Cell. 2017; 65(1):8-24. DOI: 10.1016/j.molcel.2016.11.003. View

19.

Fong J, Pignata L, Goy P, Kawabata K, Chun-Wei Lee S, Koh C . Therapeutic Targeting of RNA Splicing Catalysis through Inhibition of Protein Arginine Methylation. Cancer Cell. 2019; 36(2):194-209.e9. PMC: 7194031. DOI: 10.1016/j.ccell.2019.07.003. View

20.

Jansson M, Durant S, Cho E, Sheahan S, Edelmann M, Kessler B . Arginine methylation regulates the p53 response. Nat Cell Biol. 2008; 10(12):1431-9. DOI: 10.1038/ncb1802. View